These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 521251)

  • 41. [Sustained specific desensitization in a patient with diabetes mellitus with insulin allergy under conditions of immunoglobulin control].
    Dreval' AV; Mutina ES; Iuldashev AK; Serova TI; Sitnikova ND
    Probl Endokrinol (Mosk); 1978; 24(4):51-4. PubMed ID: 683971
    [No Abstract]   [Full Text] [Related]  

  • 42. Insulin resistance and new insulins.
    Yue DK; Turtle JR
    Aust Fam Physician; 1977 Mar; 6(3):286, 289. PubMed ID: 869782
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunogenicity of bovine, porcine and semisynthetic human insulin.
    Venekamp WJ; van der Hooft JC; Jacobsen L; van Schaik CL
    Neth J Med; 1985; 28 Suppl 1():57-8. PubMed ID: 3892343
    [No Abstract]   [Full Text] [Related]  

  • 44. New insulins: their role in the treatment of diabetes.
    Caterson I
    Drugs; 1979 Apr; 17(4):289-96. PubMed ID: 456293
    [No Abstract]   [Full Text] [Related]  

  • 45. Insulin antibody formation. I. The influence of age, sex, infections, insulin dosage and regulation of diabetes.
    Andersen OO
    Acta Endocrinol (Copenh); 1972 Sep; 71(1):126-40. PubMed ID: 4678008
    [No Abstract]   [Full Text] [Related]  

  • 46. Insulin-binding antibodies in diabetic patients and their relationship to insulin treatment.
    Ditzov SP; Penchev IG; Andreev DC; Tarkolev NT; Sirakov LM
    Acta Diabetol Lat; 1974; 11(2):106-11. PubMed ID: 4432726
    [No Abstract]   [Full Text] [Related]  

  • 47. Insulin antibodies and clinical complications in diabetics treated for five years with lente or sulfated insulin.
    Little JA; Lee R; Sebriakova M; Csima A
    Diabetes; 1977 Oct; 26(10):980-8. PubMed ID: 561729
    [No Abstract]   [Full Text] [Related]  

  • 48. Measurement of immune complexes in insulin-treated diabetics.
    Jayarao KS; Faulk WP; Karam JH; Grodsky GM; Forsham PH
    J Immunol Methods; 1973 Dec; 3(4):337-45. PubMed ID: 4591347
    [No Abstract]   [Full Text] [Related]  

  • 49. Circulating insulin antibodies during therapy with highly purified neutrally buffered insulins including desphe insulins. Report of a prospective study with 40 cases.
    Kühnau J; Rüdiger H; Goetz K
    Exp Clin Endocrinol; 1984 Apr; 83(2):161-7. PubMed ID: 6373318
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunogenicity of human insulin (Novo) or pork monocomponent insulin in HLA-DR-typed insulin-dependent diabetic individuals.
    Schernthaner G; Borkenstein M; Fink M; Mayr WR; Menzel J; Schober E
    Diabetes Care; 1983; 6 Suppl 1():43-8. PubMed ID: 6343038
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Animal insulins.
    Moses SG; Kapur A
    J Assoc Physicians India; 1997; Suppl 1():41-4. PubMed ID: 11235635
    [No Abstract]   [Full Text] [Related]  

  • 52. Clinical aspects of monocomponent insulins in the treatment of diabetes.
    Vinik AI; Joffe BI; Seftel HC; Distiller LA; Jackson WP
    S Afr Med J; 1976 Apr; 50(15):587-91. PubMed ID: 1265555
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Equilibrium binding assay and kinetic characterization of insulin antibodies.
    Goldman J; Baldwin D; Pugh W; Rubenstein AH
    Diabetes; 1978 Jun; 27(6):653-60. PubMed ID: 658611
    [No Abstract]   [Full Text] [Related]  

  • 54. Immunogenicity of insulin of various origins.
    Reeves WG
    Neth J Med; 1985; 28 Suppl 1():43-6. PubMed ID: 3892338
    [No Abstract]   [Full Text] [Related]  

  • 55. Serological analysis of human IgG and IgE anti-insulin antibodies by solid-phase radioimmunoassays.
    Hamilton RG; Rendell M; Adkinson NF
    J Lab Clin Med; 1980 Dec; 96(6):1022-36. PubMed ID: 7000933
    [No Abstract]   [Full Text] [Related]  

  • 56. [Insulin antibodies in diabetes mellitus].
    Alekseeva GG; Egorova TV; Avenirova ZA
    Probl Endokrinol (Mosk); 1972; 18(1):42-6. PubMed ID: 5061552
    [No Abstract]   [Full Text] [Related]  

  • 57. [Proceedings: Formation of anti-insulin antibodies IgG in diabetic patients treated with conventional insulin monocomposed or monospecific].
    Weber HU; Sourisseau D; Zahnd GR
    Helv Med Acta; 1974 May; 37(5-6):367. PubMed ID: 4410557
    [No Abstract]   [Full Text] [Related]  

  • 58. The immunogenicity of insulin preparations.
    Chance RE; Root MA; Galloway JA
    Acta Endocrinol Suppl (Copenh); 1976; 205():185-98. PubMed ID: 793278
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Soluble immune complexes in the sera of newly diagnosed insulin-dependent diabetics and in treated diabetics.
    Irvine WJ; Al-Khateeb SF; Di Mario U; Feek CM; Gray RS; Edmond B; Duncan LJ
    Clin Exp Immunol; 1977 Oct; 30(1):16-21. PubMed ID: 606435
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diabetic control in patients treated with once or twice-daily insulin injections, including a comparison of conventional beef and highly purified pork insulins.
    Gray RS; Borsey DQ; Fraser DM; Kurtz AB; Rainbow S; Smith AF; Duncan LJ; Clarke BF
    Diabetologia; 1981 Sep; 21(3):206-10. PubMed ID: 7028552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.